Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Perifosine

Perifosine

pharmaceutical raw materials
Perifosine structure

Perifosine 

structure
  • CAS No:

    157716-52-4

  • Formula:

    C25H52NO4P

  • Chemical Name:

    Perifosine

  • Synonyms:

    Piperidinium,4-[[hydroxy(octadecyloxy)phosphinyl]oxy]-1,1-dimethyl-,inner salt;D 21266;Perifosine;NSC 639966;KRX 0401;(1,1-Dimethylpiperidin-1-ium-4-yl) octadecyl phosphate

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

Perifosine is an oral Akt inhibitor. All cells are sensitive to the antiproliferative properties of Perifosine with an IC50 of ~0.6-8.9 μM.


Perifosine is a phospholipid consisting of 1,1-dimethylpiperidinium-4-yl hydrogen phosphate in which the hydrogen is replaced by a stearyl (octadecyl) group. It has a role as an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor. It is a phospholipid and an ammonium betaine. It derives from an octadecan-1-ol.|Perifosine is a novel alkylphospholipid with antiproliferative properties attributed to protein kinase B inhibition.|Perifosine is an orally active alkyl-phosphocholine compound with potential antineoplastic activity. Targeting cellular membranes, perifosine modulates membrane permeability, membrane lipid composition, phospholipid metabolism, and mitogenic signal transduction, resulting in cell differentiation and inhibition of cell growth. This agent also inhibits the anti-apoptotic mitogen-activated protein kinase (MAPK) pathway and modulates the balance between the MAPK and pro-apoptotic stress-activated protein kinase (SAPK/JNK) pathways, thereby inducing apoptosis. Perifosine has a lower gastrointestinal toxicity profile than the related agent miltefosine. (NCI04)

Perifosine Basic Attributes

461.663

461.363403

1592732-453-0

2GWV496552

639966

DTXSID3048946

C1727

2933399090

Characteristics

58.6

8.3

white to beige

271-272° (dec)

H2O: soluble10mg/mL, clear

-20°C

Safety Information

NONH for all modes of transport

P201, P202, P260, P263, P264, P270, P280, P281, P301+P312, P302+P352, P305+P351+P338, P308+P313, P314, P321, P330, P332+P313, P337+P313, P362, P405, P501

H302

|Danger|H302 (90.91%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P260, P263, P264, P270, P280, P281, P301+P312, P305+P351+P338, P308+P313, P314, P330, P337+P313, P405, and P501|Aggregated GHS information provided by 11 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Investigated for use/treatment in solid tumors, multiple myeloma, leukemia (unspecified), lung cancer, and brain cancer.

Targeting cellular membranes, perifosine modulates membrane permeability, membrane lipid composition, phospholipid metabolism, and mitogenic signal transduction, resulting in cell differentiation and inhibition of cell growth. This agent also inhibits the anti-apoptotic mitogen-activated protein kinase (MAPK) pathway and modulates the balance between the MAPK and pro-apoptotic stress-activated protein kinase (SAPK/JNK) pathways, thereby inducing apoptosis.

D 21266

Perifosine Use and Manufacturing

Uses

An alkylphospholipid which inhibits Akt activation and the anti-apoptotic MAPK pathway.

Human drugs -> Rare disease (orphan)

Computed Properties

Molecular Weight:461.7
XLogP3:8.3
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:20
Exact Mass:461.36339614
Monoisotopic Mass:461.36339614
Topological Polar Surface Area:58.6
Heavy Atom Count:31
Complexity:454
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Perifosine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.